INHIBITORS OF THE CD95 SIGNALING PATHWAY FOR TREATMENT OF MDS

• 收藏
• 分享

专利权人:

Apogenix AG

发明人:

申请号：

EP16178598.5

公开号：

EP3150224B1

申请日:

2013.07.18

申请国别(地区):

EP

年份:

2018

代理人:

摘要：

The present invention relates to the inhibitor of CD95 signal pathways to be selected from the subgroups low risk MDS IPSS MDS and/or the subgroups intermediate-1 Int1 MDS IPSS (risk) using osteomyelodysplasia fault bit (MDS) for treating, and for diagnosing MDS.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/